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Positron emission tomography (PET) and magnetic resonance im-
aging (MRI) arewidely used in vivo imaging technologieswith both
clinical and biomedical research applications. The strengths of MRI
include high-resolution, high-contrastmorphologic imaging of soft
tissues; the ability to image physiologic parameters such as diffu-
sion and changes in oxygenation level resulting from neuronal
stimulation; and the measurement of metabolites using chemical
shift imaging. PET images the distribution of biologically targeted
radiotracers with high sensitivity, but images generally lack ana-
tomic context and are of lower spatial resolution. Integration of
these technologies permits the acquisition of temporally correlated
data showing the distribution of PET radiotracers andMRI contrast
agents or MR-detectable metabolites, with registration to the
underlying anatomy. An MRI-compatible PET scanner has been
built for biomedical research applications that allows data from
both modalities to be acquired simultaneously. Experiments dem-
onstrate no effect of theMRI systemon the spatial resolution of the
PET system and <10% reduction in the fraction of radioactive
decay events detected by the PET scanner inside the MRI. The
signal-to-noise ratio and uniformity of the MR images, with the
exception of one particular pulse sequence, were little affected by
the presence of the PET scanner. In vivo simultaneous PET and MRI
studies were performed in mice. Proof-of-principle in vivo MR
spectroscopy and functional MRI experiments were also demon-
strated with the combined scanner.
molecular imaging  small animal imaging  multimodality imaging
Positron emission tomography (PET) noninvasively imagesthe distribution in vivo of biomolecules (small molecules,
peptides, antibodies, and nanoparticles) labeled with radionu-
clides that undergo positron decay and produce back-to-back
511-keV annihilation photons (1). Because of the high sensitivity
of radioactive assays, PET can measure picomolar concentra-
tions of labeled biomolecules. A wide variety of molecular
targets and pathways have been imaged by using PET radiotrac-
ers (2, 3), with the avid accumulation of the radiotracer [18F]-
2-f luoro-2-deoxy-D-gluocse (FDG) in malignant tumors being
just one example that has widespread applications in the clinic
and in the study of therapeutic strategies for tumor treatment in
animal models. However, the spatial resolution of PET is limited
by physical factors associated with positron physics and by the
difficulty of acquiring sufficient counting statistics. Further-
more, PET images often lack definitive anatomic information,
making interpretation of the precise location of radiotracer
accumulation difficult.
Magnetic resonance imaging (MRI) can provide high-spatial-
resolution anatomic images with exquisite soft-tissue contrast by
exploiting the differences in relaxation times of protons in
different biochemical environments (4, 5). The combination of
high spatial resolution and contrast allows the anatomic conse-
quences (e.g., tumor growth, brain atrophy, cardiac wall motion
abnormalities) of many disease processes to be visualized in
patients and in animal models. Functional MRI techniques can
measure important physiologic parameters, including diffusion
(6, 7), permeability (8), and changes in blood oxygenation levels
after neuronal activation (9–11). The addition of passive con-
trast agents based on gadolinium or iron-oxide nanoparticles can
further enhance contrast (12). A number of laboratories are also
developing targeted MRI contrast agents (13–15). MR spectros-
copy (MRS), which measures the shift in the frequency at which
protons in different chemical environments resonate, allows the
relative concentrations of abundant metabolites, and some drugs
administered at mass levels, to be measured. With localized
MRS, coarse spectroscopic images also can be obtained (16, 17).
Proton MRS is particularly useful in tumor studies and also
offers information about neuronal integrity in neurodegenera-
tive disorders (18–21). However, the molar sensitivity of MRI
for different metabolites and tracers is many orders of magni-
tude lower than that of PET, imposing significant restrictions on
the kinds of targets that can be visualized.
Clear synergies exist between the twomodalities, because each
can provide unique information not attainable with the other
modality. For this reason, MRI and PET are frequently com-
bined in clinical diagnostics and research. Relevant to this work,
these modalities have been increasingly used in more basic
biomedical research, particularly in efforts to understand the
etiology and evolution of human diseases in appropriate animal
models (commonly mice and rats) and in the preclinical evalu-
ation of new therapeutic strategies, including small-molecule
drugs, peptides and antibodies, cellular therapies, gene therapy,
and nanoparticle-based therapies. In particular, these modalities
can be used in combination to study both the pharmacokinetics
and pharmacodynamics of new therapeutics.
To date, PET and MR images are acquired on separate
imaging systems and typically coregistered by using software that
makes use of the information content of the image data (e.g.,
landmarks) or external fiducial markers that can be clearly
identified in the two images (22). This approach works well in the
brain, where the skull constrains movement and enables simple
rigid body registration methods to be used (23). However, it
becomes more problematic in the thorax, abdomen, and pelvic
regions, where tissues and organs deform based on the position
of the subject in the scanner, and where temporal changes such
as emptying of stomach contents, movement of the food through
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the intestinal tract, and filling of the urinary bladder also
confound registration. Deformable image registration tech-
niques can be used, but their success is highly situation-
dependent, and they are not generally robust in the presence of
significant tissue movement between the two separate imaging
studies. Simultaneous acquisition, therefore, would guarantee
spatial registration of the two datasets.
More crucially, sequential PET and MRI scanning does not
permit temporal correlation of PET andMRI studies. Biological
systems are inherently dynamic, and their response to drugs and
contrast agents is strongly time-dependent. The biodistribution
of most contrast agents and drugs exhibits changes on time scales
of seconds to minutes. To ensure that a subject is being imaged
in the same physiologic state, and to correlate changes over time
in the PET and MRI signals in response to an intervention, thus
often requires that the data be acquired simultaneously. To give
just one example, one might want to monitor dynamic changes
in tumor physiology with MRI [e.g., cellularity by diffusion
measurements (24), macromolecular environment (25, 26), vas-
culature by contrast enhancement (27)] while imaging the de-
livery of a radiolabeled therapeutic agent to, or assessing the
biochemistry of, the tumor. Simultaneous acquisition of PET
and MRI data by using an integrated imaging device is, there-
fore, necessary to answer many important biomedical questions
in dynamic, living systems.
In designing an integrated scanner for simultaneous PET and
MR imaging, an obvious challenge relates to the ways in which
the PET andMRI systems can interfere with each other, leading
to major artifacts and/or image degradation. The primary con-
cerns are electromagnetic interference (EMI) and the effect of
the main magnetic field (B0) of the MRI on the detectors in the
PET scanner; however, other, more subtle, effects that need to
be considered include the induction of eddy currents, suscepti-
bility artifacts, and an increase in temperature or vibrations
induced by the running of MR sequences. The detectors [usually
based on scintillators coupled to photomultiplier tubes (PMTs)]
and associated electronics commonly used in PET scanners are
sensitive to magnetic fields and contain conducting and radio-
frequency (RF) radiating components that have the potential to
interfere with the MRI system. For instance, PMTs are affected
by even weakmagnetic fields. The PET electronics can also easily
pick up the strong RF signals generated by the RF coil in the
MRI. Furthermore, the B0 homogeneity in MRI must not be
significantly degraded by the introduction of diamagnetic or
paramagnetic materials and, where possible, any materials in-
troduced into the magnet should be arranged symmetrically to
minimize possible artifacts. Because of their high susceptibility,
ferromagnetic materials are not normally useful, or even toler-
able, within the magnetic field of the MRI and consequently are
to be avoided.
The very earliest approaches to developing MRI-compatible
PET systems used very long optical fiber connections between
the scintillator elements and the PMT to effectively eliminate
EMI between the two systems (28, 29). Although this led to
proof-of-principle data, including a small number of animal
studies, the performance of the PET scanner was poor compared
with stand-alone PET scanners, and the length of the optical
fibers made the system cumbersome. A variation on this design
(30), using a split magnet in which the PET detectors reside in
the gap and the fibers emanate radially from the magnet, offers
the prospect of improved PET performance, albeit still limited
by the transmission of scintillation light through very long optical
fibers and the low field strength of the magnet compared with
most preclinical MRI scanners.
We opt for a different approach in developing a PET scanner
insert that is compatible with existing high-field animal MRI
systems.We usemagnetic field-insensitive avalanche photodiode
(APD) detectors in place of PMTs and use very short optical
fiber bundles to appropriately position the photodetectors and
PET electronics with respect to the MRI RF and gradient coils,
to minimize interference. A detailed description of the construc-
tion of the MRI-compatible PET insert was published in ref. 31.
In brief, the PET insert comprises 16 detector modules arranged
in a symmetric ring. Each PET detector module consists of an
array of lutetium oxyorthosilicate (LSO) detectors coupled
through a bundle of bent optical fibers to a position-sensitive
APD (PSAPD) and charge-sensitive preamplifiers mounted on
a printed circuit board populated with nonmagnetic compo-
nents. All 16 modules are mounted on a carbon fiber tube, and
the crystals in the LSO arrays form eight complete detector rings
at the center of the insert [see supporting information (SI) Fig.
5A]. The PSAPDs and photodetectors are shielded by a copper
laminate and are located in the MRI scanner such that they are
axially outside of the linear region of the z-gradient field and
outside of the imaging volume defined by the RF coil (SI Fig.
5B). The detectors are cooled to 10°C using chilled dry air to
obtain optimal signal-to-noise from the PSAPDs and to mini-
mize temperature drift. Details of the PET insert geometry are
provided in SI Table 1. The PET insert is compatible with
existing preclinical MRI scanners having a clear bore of 12 cm
or greater (SI Fig. 5C). The PET insert is positioned in the MRI
scanner by using a registration scan with PET- and MRI-visible
fiducial markers such that the isocenters of the PET and MRI
fields of view (FOVs) are coincident. The PET insert is readily
removed, allowing it and the MRI scanner to be used as
independent devices.
Other groups have pursued similar approaches but without the
optical-fiber connection, placing the APDs and electronics in the
active MR imaging volume (32, 33). This approach will improve
PET performance by eliminating scintillation light loss in the
optical fibers; however, the proximity of the APDs to the RF coil
and gradients have the potential to increase interference be-
tween the systems, especially for MRI pulse sequences that
demand intensive gradient-switching and high-intensity RF
pulses.
Here we describe detailed phantom experiments performed
with our MRI-compatible PET instrument to demonstrate that
PET and MR images can be acquired simultaneously without
significant interference between the two modalities. We also
carried out a number of proof-of-principle in vivo studies to
highlight the biomedical applications for this technology.
Results and Discussion
MRI System Effects on PET Imaging. Experiments to examine the
interference between the two imaging systems when acquiring
PET and MR data simultaneously were designed to characterize
the effect of one system’s image acquisition protocol on the
other. PET detector maps (which show a histogram of the events
detected by the 8  8 scintillator elements in a particular PET
detector module when it is uniformly irradiated with a source of
511-keV annihilation photons) demonstrate a small rotation
(clockwise or anticlockwise, depending on the orientation of the
PSAPD with respect to the magnetic field) when the PET insert
is inside the magnet (Fig. 1 A and B), due to the magnetic force
on electrons moving through the silicon. However, the ability to
resolve the detector crystals, which is a key factor contributing
to the spatial resolution in PET, was not appreciably altered in
the 7-T magnet.
Acquiring an MR image requires the use of strong RF pulses
and rapidly switched magnetic field gradients that have the
potential to perturb the weak electronic signals produced by the
PET detectors. Therefore, PET measurements were taken while
running MRI sequences that are normally used in small-animal
studies, such as RARE (rapid acquisition with relaxation en-
hancement) and FLASH (fast low-angle shot). RARE is a fast
spin echo (SE) sequence in which a number of 180° rephasing
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pulses are applied after each 90° excitation pulse to create an
echo train. FLASH is based on a gradient echo (GE) sequence
in which a low flip angle and a very fast repetition rate are used.
No difference in spatial resolution [expressed in terms of
full-width-in-half-maximum (FWHM)] of the PET scanner
could be observed when operated in the MRI scanner with
RARE (1.18  0.02 mm), SE (1.19  0.01 mm), or FLASH
(1.19  0.01 mm) pulse sequences versus the spatial resolutions
of 1.19 0.01 mm measured within the magnet without running
pulse sequences. This demonstrates that there is no observable
spatial distortion of the PET data in the MRI environment. The
energy resolution of the PET detectors (which is important for
rejecting annihilation photons that have inelastically scattered in
the body and lost their positional information) is also unchanged
during MRI pulse sequences (SI Table 2). The measured abso-
lute sensitivity (fraction of radioactive decays leading to a
detected event in the PET scanner) of the PET insert was 0.6%
at the center of the FOV (CFOV). No change in sensitivity was
detected while running a standard SE sequence. However, a 10%
and 7% decrease in event rate was observed while running the
FLASH and RARE sequences, respectively. This suggests that
a small fraction of events are removed from the PET data
stream. Further experiments in which RF excitation and gradient
switching were applied separately revealed that the effect is
likely caused by the gradient switching (Fig. 1D). This interfer-
ence only occurs over a small fraction of the duty cycle of the
pulse sequence, and these events are rejected by the PET scanner
because they do not meet the pulse-height criteria.
PET System Effects on MR Imaging. The presence of the PET insert
in the magnet has the potential to cause artifacts or to degrade
the signal-to-noise ratio (SNR) in the MR signal, both of which
would reduce image quality. Therefore, MR images were com-
pared with and without the PET insert. MR images of a
structured phantom acquired in the presence of the powered
PET insert with standard pulse sequences show no distortion and
no obvious artifacts (Fig. 2 A and B). Subtracted images, in the
presence of the powered and unpowered PET insert, demon-
strate a featureless noise background (SI Fig. 6). In a separate
experiment, average SNR (Fig. 2C) and image uniformity (Fig.
2D) were measured with and without the PET insert for different
pulse sequences, using a homogeneous phantom. The largest
decrease in SNR caused by the PET insert was with the RARE
sequence (8%, P 0.0001), whereas a smaller decrease (3%,
P  0.0001) was observed for the SE sequence. Similarly, the
largest decrease in uniformity was noted for the RARE se-
quence (2%). Smaller changes (1%) were observed for the
SE sequence and no changes were noted for the FLASH
sequence.
In Vivo Small-Animal Simultaneous PET and MR Imaging. In vivo
mouse imaging studies revealed that the combined multimodal-
ity system produces consistent information in a real-world
setting. A mouse injected with 106 MC38 cells was imaged after
10 days, when the tumor had reached 9 mm in diameter.
Simultaneous imaging with FDG PET and anatomic MRI (Fig.
3A) shows a hyperintense focus of FDG uptake coincident with
the tumor site. Uptake is heterogeneous, and a region of
hyperintensity on MRI close to the center of the tumor shows
low FDG uptake (see arrow in Fig. 3A), likely indicative of
necrosis. This example shows the potential for combined PET/
MRI studies to improve the interpretation of cancer imaging
studies in heterogeneous tumors containing malignant tissue,
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Fig. 1. MR scanner effect on PET system. (A–C) Detector histograms showing
the anticlockwise (A) and clockwise (B) rotations of the crystal maps when
compared with the data acquired outside of the magnet (C). (D) PET event rate
measured under different conditions: (i) while applying only RF power (with
1,000 ms and 500 ms repetition times) and (ii) while switching the x–z gradi-
ents independently (at 100% and 50% power; 400 and 200 mT/m, respec-
tively). Baseline represents the event rate recorded without running MR
sequences.
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Fig. 2. PET insert effects on MR imaging. (A and B) SE (A) and GE (B) images
of a structured phantom acquired in the presence of the PET insert. (C and D)
SNR (C) and uniformity (D) measured for several pulse sequences with and
without the PET insert, using a uniform phantom.
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necrosis, and edema that are not separable by MRI. Whole-body
animal imaging is important in many studies (e.g., cell tracking,
imaging of primary metastasis, immunological responses in
cancer, and vascular plaque detection). Although the axial FOV
of the MRI-compatible PET insert is just 12 mm, whole-body
imaging was achieved by moving the animal bed through the two
imaging systems and acquiring data that spanned the entire
animal (Fig. 3B). This is analogous to the way in which human
whole-body imaging is done by PET. The radiotracer adminis-
tered was Na18F. The 18F-fluoride ion accumulates in the bony
structures because of its metabolic incorporation into appetite
crystals. The jaw is clearly visible in the top row, the spine can
be traced through the last 10 slices, and the bladder is seen to
accumulate cleared 18F. MR and PET images show excellent
registration along the whole body axis. This example shows the
potential of the system for whole-body studies of the biodistri-
bution of radiotracers, and the particular use of ionic 18F is
relevant to the use of PET/MRI to study the skeletal system in
models of osteoporosis, arthritis, and bone metastasis.
Beyond Morphological MRI: Advanced MR Techniques Performed in
the Presence of the PET Insert. MRS moves MR methods into the
realm of metabolic measurements, allowing the signal of abun-
dant metabolites to be imaged, albeit on a fairly coarse spatial
scale. The combination of PET and MRS measurements, there-
fore, also offers many opportunities. To demonstrate that MRS
can be performed in the presence of the powered PET insert, a
proton spectrum was acquired from a cubic voxel of size 3 3
3 mm3 positioned centrally in the normal mouse brain (Fig. 4A).
The three singlet and one doublet resonances corresponding to
N-actetylaspartate (NAA), choline (Cho), total creatine (Cr),
and lactate (LAC) peaks, respectively, can be observed in the
mouse data. By acquiring these data simultaneously with PET,
it would be possible to temporally correlate the dynamics of PET
and MRS signals. For example, choline metabolism, which is of
special interest for cancer research, could be assessed by proton
MRS, and at the same time the activity of choline kinase could
be studied by PET, using synthetic 11C- and 18F-labeled choline
analogs. Additionally, the biodistribution and metabolism of
fluorine-containing drugs could be studied simultaneously by a
combination of 18F PET in trace amounts and 19F MRS in mass
amounts.
One of the most demanding, yet useful, sequences for per-
forming functional MRI (fMRI) studies is echo planar imaging
(EPI). Because this sequence employs fast gradient switching
and strong gradients, it is potentially one of the most difficult to
perform in the combined system. As a proof of principle,
two-dimensional, four-shot EPI with diffusion-weighted images
(DWI-EPI) was achieved in the presence of the PET insert. DWI
is based on measuring the motion of the water molecules in
biological tissues, and diffusion maps can be obtained by mea-
suring the apparent diffusion coefficients (ADCs) for all of the
voxels in the region of interest. Fig. 4B shows the ADC map
calculated from five DWIs of a live mouse brain (see SI Fig. 7
for the individual images). The fidelity of the ADC map to
literature values (34) illustrates that the PET insert has no major
effect on the performance of the MR instrumentation, even
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Fig. 3. Simultaneous in vivo PET and MR imaging. (A) Mouse FDG tumor
imaging. (Upper Left) PET image, (Upper Right) MR image, and (Lower) fused
PET and MR image. One transaxial image slice is shown. (B) Fused PET and MR
images of a mouse. Transaxial sections from top of head to bladder are shown.
(Scale bars, 5 mm.) The same false-color look-up table is used in both A and B.
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Fig. 4. Advanced MR measurements. (A) In vivo MR spectroscopy; mouse 1H
brain spectrum acquired in the presence of the PET insert. (B) ADC map of an
in vivomouse brain acquired by using a four-shot EPI sequence in the presence
of the PET insert. ADC units are 103 mm2/sec. (Scale bar, 2 mm.)
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under these demanding conditions. DWI methods have proved
important for assessing the pathological processes in a number
of conditions, such as stroke and cancer. The combination of
PET and fMRI measurements would allow different phases of a
complex pharmacological response to be interrogated. For ex-
ample, PET radiolabeled substrates and ligands could be used to
study the rate of dopamine synthesis, transport, and receptor
expression, while fMRI is used to study neuronal activation after
amphetamine or cocaine stimulation.
In conclusion, we have demonstrated the feasibility of simul-
taneous PET andMRI studies, showing that, with proper design,
no major artifacts or loss in performance are seen across a range
of typical MR imaging conditions. Thus, either of the two
imaging systems performs essentially the same, whether the
other is present or not. We cannot exclude at this stage the
presence of subtle artifacts from second-order effects that may
result in small changes in signal-to-noise in one or both modal-
ities. Nevertheless, high-quality simultaneous PET and MR
studies have been demonstrated both in phantoms and in vivo. A
number of challenges remain. Although the PET scanner per-
formance is not unduly affected by the MRI system, the design
of this prototype, in terms of sensitivity, only approximates that
of first-generation animal PET scanners developed in the late
1990s (although this is still sufficient for many interesting
studies). To design a MR-compatible insert that is competitive
with current stand-alone PET systems will require a longer axial
FOV and more efficient detectors. The use of thicker, depth-
encoding detectors and a scanner design that doubles the axial
FOV, leading to a 8-fold increase in sensitivity, should be
explored. With the exception of this issue, there is no reason that
the technology developed here cannot be translated for imaging
of larger subjects, including humans.
In this work, we demonstrate that simultaneous PET andMRI
scanning is both feasible and practical in the realm of small-
animal imaging. In vivo rodent imaging presented here supports
the potential for this multimodal imaging methodology in a
number of applications, including the tracking of molecules and
cells, pharmacokinetic/pharmacodynamic studies of drug–tissue
interactions, and the functional response (via fMRI) to neuro-
receptor occupancy (via PET). Merging these two modalities
allows us to exploit, in a synergistic fashion, the tremendous
strengths of both techniques.
Materials and Methods
PET Measurements. Detector maps and energy resolution. A 68Ge source placed at
the CFOV uniformly irradiated the PET detector modules. Events were sorted
into 2D position histograms—detector crystal maps—that relate coordinates
in the histogram to the crystal of interaction. The detector contains 64
scintillator crystals arranged in an 8  8 array. Events for each crystal were
extracted, and a histogram of the pulse amplitudes for each crystal was
plotted to determine the energy resolution (FWHM of the 511-keV photopeak
divided by the photopeak amplitude). The detector maps and energy resolu-
tion for several individual crystals were measured with and without the effects
of the MRI system.
PET reconstructed spatial resolution. Small-diameter (o.d./i.d.  1.2/0.6 mm)
capillary tubes filled with 25Ci of 18F were used to assess the effect of the MRI
on the spatial resolution of the PET insert. PET data were acquired with and
without MRI pulse sequences. The datasets were sorted into sinograms and
reconstructed with a 2D filtered back-projection algorithm using a Shepp–
Logan filter cut off at the Nyquist frequency. Normalization was performed
using detector efficiencies estimated from a scan of a uniform cylindrical
phantom. The spatial resolution was measured at the CFOV and at a 10-mm
radial offset. Radial and tangential profiles were drawn through the maxi-
mum intensity pixel in the reconstructed images, and the FWHM of the point
spread function was determined.
PET sensitivity measurements. A 20-Ci 18F point source in a glass capillary tube
was used to determine the relative sensitivity of the scanner. At the CFOV, the
effect of pulse sequences was studied by recording the number of detected
events while running RARE, SE, and FLASH, applying only RF power, and while
switching the x–z gradients independently (at 100% and 50% power). The
event rates under different conditions were compared by using a two-tailed
Student t test.
MR Measurements. MR system. A Bruker 7-Tesla Biospec small-animal MR
scanner, equipped with the Bruker B-GA12 gradient coil set (12 cm i.d., 40
G/cm maximum, 0.2 GcmÅ), was used for all of the experiments described. In
addition to the standard Bruker 35-mm RF coil, a custom-made whole-body
mouse imaging coil with heating stage for the animal was developed for this
project. The homogeneous imaging region for this coil is 9 cm.
MR phantom imaging. The Ultra-Micro Hot Spot Phantom (Data Spectrum) was
filled with a solution of Prohance (Bracco Diagnostics) in water (T1 750 ms,
T2 180 ms) and used to acquire high-resolution MR images in the presence
of the powered PET insert. The diameter of the hollow channels was 0.75, 1.0,
1.35, 1.7, 2.0, and 2.4 mm, and the center-to-center spacing of the channels
was 2 the diameter. Standard SE and GE sequences were run. The matrix size
was 512  512 with a FOV of 4  4 cm2.
Signal-to-noise and uniformity measurements. A uniform signal-producing cylin-
der (2.8 cm long, 2.8 cm i.d.) filled with Prohance in was water positioned at
the isocenter of the gradient set. The signal and noise were measured in a
region of interest (ROI) placed centrally on the MR image. The ROI was chosen
to be small enough to avoid any significant contribution from nonuniformity.
Two scans were acquired sequentially with the same parameters, and the
images were subtracted. The signal was estimated as the mean pixel value in
one of the images and the noise as the standard deviation of the pixel values
in the difference image.
For uniformity measurements, a large ROI placed centrally on the image
and avoiding the edges was chosen, and the uniformity (U) was calculated
with the formula U 100 [1 (ROImax ROImin)/(ROImax ROImin)], where
ROImax is the maximum signal intensity in the region and ROImin is the mini-
mum signal intensity in the region. The measurements were repeated for
axial, coronal, and sagittal slices, while running standard SE, RARE, and FLASH
sequences, with and without the PET insert present. In each case, 25 contig-
uous slices were defined (slice thickness 0.750 mm), and the matrix size was
256  256 with a 35  35 mm2 FOV. Data were analyzed by using ImageJ
software (National Institutes of Health). The results were compared by using
a two-tailed Student t test.
In Vivo Animal Studies. PET/MR data acquisition setup. For each of the 16 PET
detector modules, the lower level discriminator was set just above the noise
level. The coincidence timing window was set to 50 ns, and, except for basic
normalization of detector efficiencies by using a uniform cylindrical phantom,
no other corrections were applied to the PET data. The PET images were
reconstructed by using a fully 3D ML–EM algorithm (35) and fused with the MR
images that were acquired simultaneously. The voxel size in all cases was
0.35  0.35  0.75 mm3.
For the MR data acquisition, the coil was tuned and matched to its optimum
before each experiment. First-order shimming was performed using an auto-
matic procedure. In all cases, the sequence parameters (i.e., repetition time
and number of excitations) were adjusted such that the acquisition times of
the PET and MR data were similar.
Animal preparation. All animal experiments were performed under a protocol
approved by the California Institute of Technology and University of Califor-
nia, Davis, Animal Care and Use Committees. The temperature inside the coil
where the animal was placed was maintained at 37°C, and respiration was
monitored. The mice were anesthetized by isoflurane inhalation (1% in 100%
oxygen, IsoFlo; Abbot Laboratories).
Tumor imaging. A mouse with a flank tumor (106 MC38 cells injected 10 days
before imaging) was injected with 200 Ci of FDG and scanned in three bed
positions. A total of2 106 events were included in the reconstruction. The
MR data were acquired simultaneously by using the whole-body imaging coil.
No respiratory gating was performed. A RARE sequence with TR/TE  1,000/
12.5 ms was used to acquire 25 slices (slice thickness 0.75 mm) with a FOV 4
4 cm2 and matrix size  256  256.
Whole-body imaging. To demonstrate the feasibility of this combined system for
performing whole-body imaging, a mouse was injected with200 Ci of Na18F.
The mouse was positioned inside the coil, and, for each bed position, the whole
setup (i.e., coil) was moved 8 mm. The bed positions were overlapped 4 mm
(one-third of the FOV) to account for the decreased sensitivity toward the edge
of the axial FOV, such that a total of 68 mm was covered in this direction. The data
were acquired for 6 min for each bed position and corrected for radioactive
decay. The MR data were acquired simultaneously, using the whole-body imag-
ing coil. Respiratory gating was performed. A RARE sequence with TR/TE 
1,000/12.5 ms was used to acquire 31 slices (slice thickness 0.75 mm) with a FOV
4 4 cm2 and a 256 256 matrix size at each bed position.
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In vivo MR spectroscopy. Volume-selective in vivo 1H spectroscopy was per-
formed in the presence of the powered PET insert, with a cubic voxel of 33
3 mm3 positioned centrally in the mouse brain. A point-resolved spectroscopy
(PRESS) sequence with TR/TE 2,500/12 ms was used. Water suppression was
achieved by using a VAPOR module. The total acquisition time was 30 min.
EPI. A four-shot EPI sequence with linear ramp (ramp time 220 s) was used
with a 25-mm head-only RF coil with TR/TE  2,000/32 ms, bandwidth  250
kHz, and 16 averages, for a total acquisition time of10 min. Five slices were
acquired with FOV 1.92 1.92 cm, matrix size 128 128, slice thickness
0.75 mm. For diffusion weighting: 14 ms;  7 ms; five b values were used
(100, 200, 600, 800, and 1,400  103 sec/mm2) along the dorsoventral direc-
tion. ADC maps were calculated in the standard manner (36).
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